| 摘要 |
<p>The invention relates to new N,N,N',N'-tetra-substituted-1,2-ethanediamine compounds of general formula (I), wherein X is a carbonyl (CO), hydroxymethylen (CHOH) or p-fluorophenyl-methylen (p-F-C6H4-CH) group and R is a benzyl group optionally substituted in p- with an halogen, or R is a 2-pyrimidinyl group with the proviso that simultaneously X may not be p-fluorophenyl-methylen (p-F-C6H4-CH) and R may not be an unsubstituted benzyl group, as well as their pharmaceutically acceptable addition salts. The compounds are potentially useful in the treatment of sigma receptor-related nervous system diseases.</p> |
